PMID: 11910665Mar 26, 2002Paper

Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy

Climacteric : the Journal of the International Menopause Society
M NozakiH Nakano

Abstract

The effect of hormone replacement therapy (HRT) on coagulation factors and fibrinolytic components in postmenopausal women was studied for 6 months to elucidate whether continuous HRT has an influence on thrombosis. One hundred and thirty-four postmenopausal women were divided into three groups according to treatment: 39 women who had undergone hysterectomy and oophorectomy received 0.625 mg/day of conjugated equine estrogen (CEE) continuously (CEE therapy), 48 postmenopausal women received both 0.625 mg/day of CEE and 2.5 mg/day of medroxyprogesterone acetate (MPA) continuously (CEE/MPA therapy) and 47 postmenopausal women received placebo as control. The following variables were measured before treatment as well as after 1, 3 and 6 months of treatment: factor VII activity, protein C activity, fibrinogen level, antithrombin III activity, plasminogen activator inhibitor-1 (PAI-1) level and the plasma concentration of tissue-type plasminogen activator (t-PA). After 1 month of treatment, protein C activity increased by 9.6% and 11.4% of the initial value (p < 0.05), fibrinogen level decreased by 7.8% and 6.1% of the initial value (p < 0.05) and PAI-1 decreased by 19.4% and 14.3% of the initial value (p < 0.05) in the CEE therapy ...Continue Reading

References

May 1, 1979·American Journal of Clinical Pathology·T ExnerK A Rickard
Oct 1, 1992·British Journal of Obstetrics and Gynaecology·M FalkebornT Naessén
Mar 1, 1992·The American Journal of Medicine·R A Lobo
Apr 10, 1991·JAMA : the Journal of the American Medical Association·E Barrett-Connor, T L Bush
Oct 1, 1990·British Journal of Obstetrics and Gynaecology·T SporrongM Hellgren
Apr 1, 1987·Thrombosis Research·H Vinazzer, U Pangraz
Jul 1, 1987·British Journal of Obstetrics and Gynaecology·K HuntM Coleman
Oct 24, 1985·The New England Journal of Medicine·M J StampferC H Hennekens
Sep 1, 1981·American Journal of Obstetrics and Gynecology·M NotelovitzR Carter
Nov 1, 1982·American Journal of Obstetrics and Gynecology·C A MashchakD R Mishell
Sep 1, 1995·American Journal of Obstetrics and Gynecology·R A Lobo
Nov 15, 1995·Journal of the American College of Cardiology·S A Samaan, M H Crawford

❮ Previous
Next ❯

Citations

Dec 31, 2003·The Journal of Surgical Research·Lauren BakerDaniel R Meldrum
May 24, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Roger E Peverill
May 12, 2006·The Neurologist·Victor W Henderson
Jun 18, 2014·Menopause : the Journal of the North American Menopause Society·Marianne Canonico
Jun 21, 2006·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Herbert Kuhl, John Stevenson
Oct 29, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Ireneusz PolacPawel Nowak
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Victor W Henderson
Nov 11, 2008·Climacteric : the Journal of the International Menopause Society·S O SkoubyJ Jespersen
Dec 13, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Anne KalelaSeppo T Nikkari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

© 2022 Meta ULC. All rights reserved